Pharmacovigilance in palliative care
Date
2014
Authors
Rowett, D.
Currow, D.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Australian Prescriber, 2014; 37(6):204-208
Statement of Responsibility
Conference Name
Abstract
Patients receiving palliative care are at high risk of adverse effects from drugs. As these effects can be difficult to distinguish from the symptoms of the terminal illness, harm from medicines is often not recognised. Adverse effects can contribute to the burden of symptoms, at a time when good control of symptoms is paramount. Adding another drug to treat the adverse effects can compound the problem. Patients should be asked about their symptoms as they may not volunteer the information or recognise the link with their medicines. Reviewing their treatment may prompt a change in dose, drug or lead to some treatments being stopped.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright 2014 Australian Government Publishing Service